Utility of contrast‐enhanced harmonic endoscopic ultrasonography for predicting the prognosis of pancreatic neuroendocrine neoplasms

Pancreatic neuroendocrine neoplasms (PanNENs), including Grade 1 (G1) or G2 tumors, can have a poor prognosis. This study investigated the value of contrast‐enhanced harmonic endoscopic ultrasonography (CH‐EUS) for predicting the prognosis of PanNENs.

[1]  K. Yane,et al.  Endoscopic ultrasound‐guided fine needle aspiration for diagnosing pancreatic mass in patients with surgically altered upper gastrointestinal anatomy , 2020, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[2]  A. Irisawa,et al.  Safety and efficacy of endoscopic ultrasound‐guided fine needle aspiration for pancreatic masses: A prospective multicenter study , 2019, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[3]  M. Nojima,et al.  Non‐negligible rate of needle tract seeding after endoscopic ultrasound‐guided fine‐needle aspiration for patients undergoing distal pancreatectomy for pancreatic cancer , 2019, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[4]  M. Kudo,et al.  Intestinal dysbiosis mediates experimental autoimmune pancreatitis via activation of plasmacytoid dendritic cells. , 2019, International immunology.

[5]  P. Ituarte,et al.  Lymphovascular Invasion Predicts Lymph Node Involvement in Small Pancreatic Neuroendocrine Tumors , 2019, Neuroendocrinology.

[6]  S. Horiguchi,et al.  Contrast-enhanced harmonic endoscopic ultrasound using time–intensity curve analysis predicts pathological grade of pancreatic neuroendocrine neoplasm , 2019, Journal of Medical Ultrasonics.

[7]  D. Rahal,et al.  Pancreatic Neuroendocrine Tumours: The Role of Endoscopic Ultrasound Biopsy in Diagnosis and Grading Based on the WHO 2017 Classification , 2019, Digestive Diseases.

[8]  M. Kudo,et al.  Value of contrast‐enhanced harmonic endoscopic ultrasonography with enhancement pattern for diagnosis of pancreatic cancer: A meta‐analysis , 2019, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[9]  S. Varadarajulu,et al.  In memoriam: Fine‐needle aspiration, birth: Fine‐needle biopsy: The changing trend in endoscopic ultrasound‐guided tissue acquisition , 2018, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[10]  Petar Noack,et al.  Accuracy of grading pancreatic neuroendocrine neoplasms with Ki‐67 index in fine‐needle aspiration cellblock material , 2018, Cytopathology : official journal of the British Society for Clinical Cytology.

[11]  J. Ryu,et al.  Natural History of Small Pancreatic Lesions Suspected to Be Nonfunctioning Pancreatic Neuroendocrine Tumors , 2018, Pancreas.

[12]  Song-Cheol Kim,et al.  Grading by the Ki-67 Labeling Index of Endoscopic Ultrasound–Guided Fine Needle Aspiration Biopsy Specimens of Pancreatic Neuroendocrine Tumors Can Be Underestimated , 2018, Pancreas.

[13]  T. Yoshiura,et al.  Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic adenocarcinoma treated with chemotherapy , 2018, European Radiology.

[14]  A. Sauvanet,et al.  Contrast harmonic EUS for the prediction of pancreatic neuroendocrine tumor aggressiveness (with videos). , 2018, Gastrointestinal endoscopy.

[15]  R. Factor,et al.  Evaluation of the SharkCore® needle for EUS-guided core biopsy of pancreatic neuroendocrine tumors , 2018, Endoscopic ultrasound.

[16]  M. Kudo,et al.  Characterization of Pancreatic Tumors with Quantitative Perfusion Analysis in Contrast-Enhanced Harmonic Endoscopic Ultrasonography , 2017, Oncology.

[17]  Dong Wook Lee,et al.  Diagnosis of Pancreatic Neuroendocrine Tumors , 2017, Clinical endoscopy.

[18]  V. Ambrosini,et al.  Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis , 2017, Annals of Surgical Oncology.

[19]  R. Lloyd,et al.  WHO classification of tumours of endocrine organs , 2017 .

[20]  Eun Sun Lee,et al.  Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study. , 2017, Radiology.

[21]  Y. Ku,et al.  Microscopic venous invasion in patients with pancreatic neuroendocrine tumor as a potential predictor of postoperative recurrence. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[22]  Y. Eishi,et al.  Macroscopic morphology for estimation of malignant potential in pancreatic neuroendocrine neoplasm , 2016, Journal of Cancer Research and Clinical Oncology.

[23]  S. Libutti,et al.  Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors. , 2016, Surgery.

[24]  J. K. Lee,et al.  Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs) , 2014, Medicine.

[25]  T. Saibara,et al.  Evaluation of Ki-67 index in EUS–FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors , 2013, Endoscopy.

[26]  M. Falconi,et al.  Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. , 2013, The Journal of clinical endocrinology and metabolism.

[27]  E. Fishman,et al.  Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT. , 2013, AJR. American journal of roentgenology.

[28]  J. Fletcher,et al.  Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. , 2012, Surgery.

[29]  A. Sundin.  Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours. , 2012, Best practice & research. Clinical gastroenterology.

[30]  Walter G. Park,et al.  Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis , 2012, Annals of Surgical Oncology.

[31]  Masahiro Okada,et al.  Characterization of Small Solid Tumors in the Pancreas: The Value of Contrast-Enhanced Harmonic Endoscopic Ultrasonography , 2012, The American Journal of Gastroenterology.

[32]  P. Tonino,et al.  Microvessel Density Is Associated with VEGF and α-SMA Expression in Different Regions of Human Gastrointestinal Carcinomas , 2011, Cancers.

[33]  A. Haynes,et al.  Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. , 2011, Archives of surgery.

[34]  Ben Lawrence,et al.  The epidemiology of gastroenteropancreatic neuroendocrine tumors. , 2011, Endocrinology and metabolism clinics of North America.

[35]  J. Potter,et al.  Incidence rates of exocrine and endocrine pancreatic cancers in the United States , 2010, Cancer Causes & Control.

[36]  C. Schade-Brittinger,et al.  Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  C. Schade-Brittinger,et al.  Placebo-Controlled , Double-Blind , Prospective , Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors : A Report From the PROMID Study Group , 2009 .

[38]  G. Kaltsas,et al.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations , 2008, Neuroendocrinology.

[39]  Manal M. Hassan,et al.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  F. Miller,et al.  MRI of islet cell tumors of the pancreas. , 2006, AJR. American journal of roentgenology.

[41]  Oriol Casanovas,et al.  Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. , 2005, Cancer cell.

[42]  A. Harris,et al.  Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression , 2004, British Journal of Cancer.

[43]  K. Awai,et al.  Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dynamic CT involving injection protocol with dose tailored to patient weight. , 2004, Radiology.

[44]  F. Pilleul,et al.  Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. , 2003, Gastroenterology.